Wayne K Goodman1, Tanya K Murphy, Eric A Storch. 1. Department of Psychiatry, University of Florida College of Medicine, McKnight Brain Institute, Room L4-100, P.O. Box 100256, Gainesville, FL 32610-0256, USA. wkgood@psychiatry.ufl.edu
Abstract
OBJECTIVES: This article reviews evidence that led the Food and Drug Administration to issue a "black box" warning about the risk of "suicidality" (suicidal thoughts and behavior) in children and adolescents during treatment with antidepressants. RESULTS: Re-analysis of data from randomized clinical trials of antidepressants in the pediatric population revealed a significantly greater overall (all drugs across all indications) risk ratio for drug 1.95 (95% Cl, 1.28-2.98) compared to placebo in this sample of approximately 4,000 subjects. DISCUSSION: The essential message of the "black box" is to remind prescribers and consumers about the importance of monitoring closely for adverse behavioral changes during the initiation of (or changes in) antidepressant therapy. Possible mechanisms that might account for this phenomenon, particularly the so-called activation syndrome, are discussed. CONCLUSION: Empirical studies are needed to identify the precursors of suicidality and to predict which individuals are most susceptible to adverse behavioral side effects of antidepressants.
OBJECTIVES: This article reviews evidence that led the Food and Drug Administration to issue a "black box" warning about the risk of "suicidality" (suicidal thoughts and behavior) in children and adolescents during treatment with antidepressants. RESULTS: Re-analysis of data from randomized clinical trials of antidepressants in the pediatric population revealed a significantly greater overall (all drugs across all indications) risk ratio for drug 1.95 (95% Cl, 1.28-2.98) compared to placebo in this sample of approximately 4,000 subjects. DISCUSSION: The essential message of the "black box" is to remind prescribers and consumers about the importance of monitoring closely for adverse behavioral changes during the initiation of (or changes in) antidepressant therapy. Possible mechanisms that might account for this phenomenon, particularly the so-called activation syndrome, are discussed. CONCLUSION: Empirical studies are needed to identify the precursors of suicidality and to predict which individuals are most susceptible to adverse behavioral side effects of antidepressants.
Authors: Anne-Claude Bedard; Shana Nichols; José A Barbosa; Russell Schachar; Gordon D Logan; Rosemary Tannock Journal: Dev Neuropsychol Date: 2002 Impact factor: 2.253
Authors: Gregory K Brown; Thomas Ten Have; Gregg R Henriques; Sharon X Xie; Judd E Hollander; Aaron T Beck Journal: JAMA Date: 2005-08-03 Impact factor: 56.272
Authors: John March; Susan Silva; Stephen Petrycki; John Curry; Karen Wells; John Fairbank; Barbara Burns; Marisa Domino; Steven McNulty; Benedetto Vitiello; Joanne Severe Journal: JAMA Date: 2004-08-18 Impact factor: 56.272
Authors: Eric A Storch; Elysse B Arnold; Anna M Jones; Chelsea M Ale; Jeffrey J Wood; Jill Ehrenreich-May; Adam B Lewin; P Jane Mutch; Tanya K Murphy Journal: Child Psychiatry Hum Dev Date: 2012-10
Authors: Jeannette M Reid; Eric A Storch; Tanya K Murphy; Danielle Bodzin; P Jane Mutch; Heather Lehmkuhl; Michael Aman; Wayne K Goodman Journal: Child Youth Care Forum Date: 2010-02-04
Authors: Joseph F McGuire; Adam B Lewin; Daniel A Geller; Ashley Brown; Kesley Ramsey; Jane Mutch; Andrew Mittelman; Jamie Micco; Cary Jordan; Sabine Wilhelm; Tanya K Murphy; Brent J Small; Eric A Storch Journal: Neuropsychiatry (London) Date: 2012-08
Authors: Regina Bussing; Tanya K Murphy; Eric A Storch; Joseph P H McNamara; Adam M Reid; Cynthia W Garvan; Wayne K Goodman Journal: Psychiatry Res Date: 2012-09-29 Impact factor: 3.222
Authors: Alessandro S De Nadai; Marc S Karver; Tanya K Murphy; Mark A Cavitt; Jeffrey L Alvaro; Michael Bengtson; Saundra Stock; Andrew C Rakhshani; Eric A Storch Journal: J Child Adolesc Psychopharmacol Date: 2016-04-29 Impact factor: 2.576
Authors: Oz Malkesman; Daniel S Pine; Tyson Tragon; Daniel R Austin; Ioline D Henter; Guang Chen; Husseini K Manji Journal: Trends Pharmacol Sci Date: 2009-03-05 Impact factor: 14.819
Authors: Sheree L Toth; Elizabeth D Handley; Jody Todd Manly; Robin Sturm; Tangeria R Adams; Elizabeth M Demeusy; Dante Cicchetti Journal: J Abnorm Child Psychol Date: 2020-10